Acceleration of murine amyloidosis by implantation of amyloid-containing grafts

Amyloid

Volumn 12, Issue 4, 2005, Pages 226-232

  Ono, Sayako ^a,c   Cui, Dan ^a   Kunitsugu, Ichiro ^a   Hoshii, Yoshinobu ^a   Kawano, Hiroo ^a   Takahashi, Mutsuo ^a   Gondo, Toshikazu ^b   Ishihara, Tokuhiro ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

^c YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AA amyloid; AApoaII amyloid; AEF; Amyloid containing graft; Casein; Mouse

Indexed keywords

AMYLOID A PROTEIN; AMYLOID PROTEIN;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COURSE EVALUATION; DISEASE COURSE; DISEASE TRANSMISSION; FEMALE; INFLAMMATORY INFILTRATE; LIVER GRAFT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; REACTION TIME; SPECIES COMPARISON; TISSUE GRAFT;

AMYLOID; AMYLOIDOSIS; ANIMALS; APOLIPOPROTEIN A-II; FEMALE; HUMANS; INFLAMMATION; MICE; MICE, INBRED AKR; MICE, INBRED ICR; TISSUE TRANSPLANTATION; TRANSPLANTS;

EID: 30744433612     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120500363583     Document Type: Article

References (22)

1. Fu X, Korenaga T, Fu L, Xing Y, Guo Z, Matsushita T, Hosokawa M, Naiki H, Baba S, Kawata Y, Ikeda S, et al. Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils. FEBS Lett 2004;563:179-184.
2. Niewold ThA., Gruys E, Kisilevsky R, Shirahama TS. Fibril amyloid enhancing factor (FAEF)-accelerated amyloidosis in the hamster is not dependent on senile esterase activity and mononuclear phagocytosis. Scand J Immunol 1991;34:101-107.
3. Mambule C, Ando Y, Anan I, Holmgren G, Sandgren O, Stigbrandt T, Tashima K, Suhr OB. Enhancement of AA-amyloid formation in mice by transthyretin amyloid fragments and polyethylene glycol. Biochem Biophys Acta 2000;1474:331-336.
4. Johan K, Westermark G, Engström U, Gustavsson Å, Hultman P, Westermark P. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 1998;95:2559-2563.
5. Ganowiak K, Hultman P, Engström U, Gustavsson Å, Westermark P. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. Biochem Biophys Res Comm 1994;199:306-312.
6. Yokota T, Ishihara T, Kawano H, Takahashi M, Fujinaga Y, Uchino F. Amyloid enhancing factor (AEF) in the aging mouse. Virchows Arch A Pathol Anat Histopathol 1989;414:511-514.
7. Elliott-Bryant R, Cathcart ES. Amyloid enhancing factor and dietary transmission in accelerated amyloid A amyloidosis. Clin Immunol Immunopathol 1998;88:65-69.
8. Suhr OB, Herlenius G, Friman S, Ericzon BG. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl 2000;6:263-276.
9. Furtado AJL. Domino liver transplantation using FAP grafts. HUC experience-hopes and realities. Amyloid: J Protein Folding Disord 2003;10 (Suppl 1):84-87.
10. Suhr OB. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications. Amyloid:J. Protein Folding Disord 2003;10 (Suppl 1):77-83.
11. Ericzon BG, Larsson M, Herlenius G, Wilczek HE on behalf of reporting members of the FAPWTR: Report from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR) and the Domino Liver Transplant Registry (DLTR). Amyloid: J Protein Folding Disord 2003;10 (Suppl 1):67-76.
12. Ando Y. New therapeutic approaches for familial amyloidotic polyneuropathy (FAP). Amyloid: J Protein Folding Disord 2003;10 (Suppl 1):55-66.
13. Stangou AJ, Heaton ND, Hawkins PN. Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation [Case Reports. Letter]. N Engl J Med 2005;352:2356.
14. Gruys E, Snel FW. Animal models for reactive amyloidosis. Bailliére's Clin Rheumatol 1994;8:599-611.
15. Skinner M, Shirahama T, Benson MD, Cohen AS. Murine amyloid protein AA in casein-induced experimental amyloidosis. Lab Invest 1977;36:420-427.
16. Imada N. Pathological study on amyloidosis, isolation and purification of amyloid fibril protein and biochemical and immunological analysis. Yamaguchi Med J 1981;30:149-162 (In Japanese).
17. Higuchi K, Matsumura A, Honma A, Takeshita S, Hashimoto K, Hosokawa M, Yasuhira K, Takeda T. Systemic senile amyloid in senescence-accelerated mice. A unique fibril protein demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. Lab Invest 1983;48:231-240.
18. Horwich AJ, Weissman JS. Deadly conformations-Protein misfolding in Prion disease. Cell 1997;89:499-510.
19. Lundmark K, Westermark GT, Nyström S, Murphy CL, Solomon A, Westermark P. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci USA 2002;99:6979-6984.
20. SAM amyloidosis in mice presents universally as a systemic age-associated amyloidosis. Virchows Archiv B Cell Pathol Incl Mol Pathol 1991;60:231-238.
21. Higuchi K, Kogishi K, Wang J, Chen X, Chiba T, Matsushita T, Hoshii Y, Kawano H, Ishihara T, Yokota T, Hosokawa M. Fibrilization in mouse senile amyloidosis is fibril conformation-dependent. Lab Invest 1998;78:1535-1542.
22. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999;400:173-177.